| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/SMLL.200900626 |
| P698 | PubMed publication ID | 19743433 |
| P2093 | author name string | Susan Newbigging | |
| Warren C W Chan | |||
| Hans C Fischer | |||
| Robin E Anderson | |||
| Tanya S Hauck | |||
| P433 | issue | 1 | |
| P921 | main subject | toxicity | Q274160 |
| quantum dot | Q1133068 | ||
| P304 | page(s) | 138-144 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Small | Q3486838 |
| P1476 | title | In vivo quantum-dot toxicity assessment | |
| P478 | volume | 6 |
| Q39675461 | A novel clinically translatable fluorescent nanoparticle for targeted molecular imaging of tumors in living subjects |
| Q62267331 | A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots |
| Q39538071 | A strategy to assemble nanoparticles with polymers for mitigating cytotoxicity and enabling size tuning |
| Q43450285 | Acute and subchronic toxicity evaluation of poly(ε-caprolactone) lipid-core nanocapsules in rats. |
| Q93184904 | Advances in nanocarriers as drug delivery systems in Chagas disease |
| Q37935029 | Applications of upconversion nanoparticles in imaging, detection and therapy |
| Q33734403 | Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma |
| Q33706436 | BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer |
| Q46122601 | Biodistribution of intact fluorescent CdSe/CdS/ZnS quantum dots coated by mercaptopropionic acid after intravenous injection into mice. |
| Q38805045 | Bioinspired fluorescent dipeptide nanoparticles for targeted cancer cell imaging and real-time monitoring of drug release |
| Q33357976 | CLAVATA3 dodecapeptide modified CdTe nanoparticles: a biocompatible quantum dot probe for in vivo labeling of plant stem cells |
| Q49058815 | Cabazitaxel and indocyanine green co-delivery tumor-targeting nanoparticle for improved antitumor efficacy and minimized drug toxicity |
| Q39157376 | Cadmium-containing quantum dots: properties, applications, and toxicity |
| Q35125461 | Capillary electrophoresis of quantum dots: minireview |
| Q50535026 | Characterization of CdHgTe/CdS QDs for Near Infrared Fluorescence Imaging of Spinal Column in a Mouse Model |
| Q40736223 | Characterizing the biocompatibility and tumor-imaging capability of Cu₂S nanocrystals in vivo |
| Q60947273 | Chlorotoxin-A Multimodal Imaging Platform for Targeting Glioma Tumors |
| Q38176231 | Colloidal silicon quantum dots: from preparation to the modification of self-assembled monolayers (SAMs) for bio-applications. |
| Q40476501 | Complete prevention of blood loss with self-sealing haemostatic needles. |
| Q62513736 | Cytotoxicity investigation of luminescent nanohybrids based on chitosan and carboxymethyl chitosan conjugated with BiS quantum dots for biomedical applications |
| Q49370039 | Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties |
| Q37728142 | Diverse Applications of Nanomedicine |
| Q40063129 | Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer. |
| Q89736503 | Effects of Cd-based Quantum Dot Exposure on the Reproduction and Offspring of Kunming Mice over Multiple Generations |
| Q39630836 | Effects of Cell Culture Media on the Dynamic Formation of Protein−Nanoparticle Complexes and Influence on the Cellular Response |
| Q53468662 | Effects of N-acetyl-L-cysteine-capped CdTe quantum dots on bovine serum albumin and bovine hemoglobin: isothermal titration calorimetry and spectroscopic investigations. |
| Q33839384 | Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques |
| Q47176731 | Emission Tuning with Size-Controllable Polymer Dots from a Single Conjugated Polymer. |
| Q52674872 | Engineering Immunological Tolerance Using Quantum Dots to Tune the Density of Self-Antigen Display. |
| Q41030674 | Engineering of silicon surfaces at the micro- and nanoscales for cell adhesion and migration control. |
| Q38137210 | Evaluating pharmacokinetics and toxicity of luminescent quantum dots |
| Q38845001 | Evaluation of biological activity of quantum dots in a microsystem. |
| Q58573368 | Expression and significance of quantum dots in RAW 264.7 macrophages |
| Q36927337 | Facile synthesis, silanization, and biodistribution of biocompatible quantum dots |
| Q38017153 | Fluorescence in nanobiotechnology: sophisticated fluorophores for novel applications |
| Q38009197 | Fluorescent nanoprobes dedicated to in vivo imaging: from preclinical validations to clinical translation. |
| Q35638703 | Functionalization of graphene oxide nanostructures improves photoluminescence and facilitates their use as optical probes in preclinical imaging |
| Q39148070 | Functionalized quantum dots induce proinflammatory responses in vitro: the role of terminal functional group-associated endocytic pathways |
| Q30388290 | Genotoxicity and Cytotoxicity of Cadmium Sulfide Nanomaterials to Mice: Comparison Between Nanorods and Nanodots |
| Q48013570 | Health implications of engineered nanomaterials |
| Q33856349 | Heme oxygenase expression as a biomarker of exposure to amphiphilic polymer-coated CdSe/ZnS quantum dots |
| Q36078343 | Hepatotoxicity assessment of Mn-doped ZnS quantum dots after repeated administration in mice |
| Q57376708 | Hepatotoxicity induced by ZnO quantum dots in mice |
| Q43924951 | High-resolution three-photon biomedical imaging using doped ZnS nanocrystals |
| Q37708403 | Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light. |
| Q28386055 | Immunotoxicity assessment of CdSe/ZnS quantum dots in macrophages, lymphocytes and BALB/c mice |
| Q47174052 | Immunotoxicological impact and biodistribution assessment of bismuth selenide (Bi2Se3) nanoparticles following intratracheal instillation in mice |
| Q38261949 | Impacts of quantum dots in molecular detection and bioimaging of cancer. |
| Q92923829 | In vivo Toxicity Investigation of Magnesium Oxide Nanoparticles in Rat for Environmental and Biomedical Applications |
| Q52743254 | In vivo assessment of CdSe-ZnS quantum dots: coating dependent bioaccumulation and genotoxicity. |
| Q41518057 | In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer. |
| Q58702427 | In vivo biodistribution and toxicology studies of cadmium-free indium-based quantum dot nanoparticles in a rat model |
| Q37906630 | In vivo biodistribution of nanoparticles |
| Q37428893 | In vivo imaging of lymphatic drainage of cerebrospinal fluid in mouse |
| Q35784601 | In vivo molecular imaging of colorectal cancer using quantum dots targeted to vascular endothelial growth factor receptor 2 and optical coherence tomography/laser-induced fluorescence dual-modality imaging |
| Q38222429 | Inorganic Nanoparticles for Therapeutic Delivery: Trials, Tribulations and Promise |
| Q37749564 | Inorganic nanomaterials for tumor angiogenesis imaging. |
| Q34644628 | Inorganic nanoparticle-based contrast agents for molecular imaging |
| Q57345360 | Light Harvesting and Photoemission by Nanoparticles for Photodynamic Therapy |
| Q52671068 | Linking Subcellular Disturbance to Physiological Behavior and Toxicity Induced by Quantum Dots in Caenorhabditis elegans. |
| Q36247267 | Liver Toxicity of Cadmium Telluride Quantum Dots (CdTe QDs) Due to Oxidative Stress in Vitro and in Vivo |
| Q39029945 | Long lived BSA Au clusters as a time gated intensity imaging probe. |
| Q55709952 | Long-term in vivo biodistribution and toxicity study of functionalized near-infrared persistent luminescence nanoparticles. |
| Q37903284 | Making carbon nanotubes biocompatible and biodegradable |
| Q37462904 | Mechanism of hard-nanomaterial clearance by the liver. |
| Q38136245 | Metallic nanoparticles and their medicinal potential. Part II: aluminosilicates, nanobiomagnets, quantum dots and cochleates |
| Q51834211 | Molecular mechanism of copper-zinc superoxide dismutase activity change exposed to N-acetyl-L-cysteine-capped CdTe quantum dots-induced oxidative damage in mouse primary hepatocytes and nephrocytes. |
| Q35572430 | Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. |
| Q37988213 | Nanomedicine and veterinary science: the reality and the practicality |
| Q35063603 | Nanomedicine strategies for treatment of secondary spinal cord injury |
| Q33759991 | Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence |
| Q28395287 | Nanoparticle Uptake: The Phagocyte Problem |
| Q36343633 | Nanoparticle targeting to neurons in a rat hippocampal slice culture model |
| Q64071926 | Nanoparticles for Bioapplications: Study of the Cytotoxicity of Water Dispersible CdSe(S) and CdSe(S)/ZnO Quantum Dots |
| Q38250517 | Nanoparticulate carriers: an emerging tool for breast cancer therapy |
| Q24599399 | Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? |
| Q38061850 | Nanotoxicity assessment of quantum dots: from cellular to primate studies |
| Q38080803 | Nanotoxicity: a growing need for study in the endocrine system |
| Q84515085 | Nanotoxicology. No signs of illness |
| Q57345630 | Nanotoxicology: Contemporary Issues and Future Directions |
| Q57340749 | Near-Infrared Fluorescent Nanomaterials for Bioimaging and Sensing |
| Q34367526 | Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges |
| Q39093458 | Particle sizing methods for the detection of protein aggregates in biopharmaceuticals |
| Q43498389 | Photoluminescent graphene oxide microarray for multiplex heavy metal ion analysis |
| Q39438953 | Quantum dot 705, a cadmium-based nanoparticle, induces persistent inflammation and granuloma formation in the mouse lung |
| Q37337213 | Quantum dot-based nanoprobes for in vivo targeted imaging |
| Q26996556 | Quantum dots as a platform for nanoparticle drug delivery vehicle design |
| Q37775545 | Quantum dots as contrast agents for in vivo tumor imaging: progress and issues |
| Q35944451 | Quantum dots for molecular diagnostics of tumors. |
| Q38380533 | Quantum dots: bright and versatile in vitro and in vivo fluorescence imaging biosensors |
| Q37285548 | Reproductive toxicity and gender differences induced by cadmium telluride quantum dots in an invertebrate model organism |
| Q37570280 | Resonance energy transfer between fluorescent BSA protected Au nanoclusters and organic fluorophores |
| Q47805874 | Review of the effects of manufactured nanoparticles on mammalian target organs. |
| Q37326472 | Selective Effects of Curcumin on CdSe/ZnS Quantum-dot-induced Phototoxicity Using UVA Irradiation in Normal Human Lymphocytes and Leukemia Cells |
| Q37000155 | Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice |
| Q41529481 | Silica-encapsulated efficient and stable si quantum dots with high biocompatibility |
| Q47424149 | Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice |
| Q35234739 | Size-dependent in vivo toxicity of PEG-coated gold nanoparticles |
| Q50483772 | Sonochemical synthesis of Ag nanoclusters: electrogenerated chemiluminescence determination of dopamine. |
| Q46812752 | Storage of gold nanoclusters in muscle leads to their biphasic in vivo clearance. |
| Q57366467 | Study on the room temperature synthesis of highly photoluminescent and temperature-sensitive CDs/PNIPAM hybrid hydrogels and their properties |
| Q28389656 | Surface biofunctionalized CdS and ZnS quantum dot nanoconjugates for nanomedicine and oncology: to be or not to be nanotoxic? |
| Q28394187 | Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains |
| Q53430898 | Synthesis and characterisation of multifunctional alginate microspheres via the in situ formation of ZnO quantum dots and the graft of 4-(1-pyrenyl) butyric acid to sodium alginate. |
| Q57352357 | Synthesis and characterization of near-infrared-emitting CdHgTe/CdS/ZnS quantum dots capped by N-acetyl-l-cysteine for in vitro and in vivo imaging |
| Q39373444 | Synthesis of NAC capped near infrared-emitting CdTeS alloyed quantum dots and application for in vivo early tumor imaging |
| Q37990022 | Tapping the potential of quantum dots for personalized oncology: current status and future perspectives |
| Q95641929 | The NLRP3-Mediated Neuroinflammatory Responses to CdTe Quantum Dots and the Protection of ZnS Shell |
| Q89736563 | The biocompatibility studies of polymer dots on pregnant mice and fetuses |
| Q39124755 | The cell-type specific uptake of polymer-coated or micelle-embedded QDs and SPIOs does not provoke an acute pro-inflammatory response in the liver |
| Q41451031 | The distribution and degradation of radiolabeled superparamagnetic iron oxide nanoparticles and quantum dots in mice |
| Q42088954 | The role of ligand coordination on the cytotoxicity of cationic quantum dots in HeLa cells |
| Q97548169 | Thermally Induced Structural Transition of Peptide Nanofibers into Nanoparticles with Enhanced Fluorescence Properties |
| Q28395587 | Time-dependent toxicity of cadmium telluride quantum dots on liver and kidneys in mice: histopathological changes with elevated free cadmium ions and hydroxyl radicals |
| Q58910709 | Tipping the Proteome with Gene-Based Vaccines: Weighing in on the Role of Nanomaterials |
| Q54985361 | Towards clinically translatable in vivo nanodiagnostics. |
| Q57351331 | Toxicity assessment of phospholipid micelle-encapsulated cadmium-based quantum dots using Kunming mice |
| Q50495685 | Toxicity of CdTe quantum dots on yeast Saccharomyces cerevisiae. |
| Q37858903 | Toxicity of nanocrystal quantum dots: the relevance of surface modifications |
| Q28393689 | Toxicity of quantum dots and cadmium salt to Caenorhabditis elegans after multigenerational exposure |
| Q34231174 | Toxicologic effects of gold nanoparticles in vivo by different administration routes |
| Q33741995 | Tracking the small with the smallest--using nanotechnology in tracking zooplankton |
| Q48216869 | Upconversion Luminescence Sensitized pH-Nanoprobes. |
| Q57497810 | toxicology of carbon dots by H NMR-based metabolomics |
Search more.